Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies
Author(s): Marianna Fontana Added: 1 year ago
Prof Marianna Fontana (University College London, UK) joined us to discuss the discovery and impact of antibody-associated reversal of ATTR amyloidosis–related cardiomyopathy in three patients. Prof Fontana and her team, in a correspondence published in The New England Journal of Medicine, revealed the identification of an antibody linked to the spontaneous reversal of cardiac transthyretin… View more

Heart Failure
Cardiovascular Effects of NSAIDs: A Review With a Focus on RA Patients
Author(s): Eirik Ikdahl , Anne Kerola , Eli Sollerud , et al Added: 6 months ago

Prevention & Chronic Conditions
Claire Lew
Research Area(s) / Expertise: Job title: ISCP Governor for Singapore & Senior Pharmacist
Ms Claire Lew is ISCP Governor for Singapore & Senior Pharmacist, Tan Tock Seng Hospital, SG. Ms Claire Lew is involved in the running of pharmacist-run cardiology clinics such as the Heart Failure Pharmacist Clinic, Post Percutaneous Intervention (PCI) Pharmacist Clinic, as well as the Anti-coagulation Services in Tan Tock Seng Hospital. ISCP Governors act as representatives for different… View more
Factor XI Inhibition and AF
Author(s): Bianca Rocca , Hugo ten Cate Added: 2 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Prioritising Risk in CAD: A Patient-First Discussion on Antiplatelet Therapy
Author(s): Felicita Andreotti , Diana Gorog , Marco Valgimigli , et al Start date: Dec 14, 2023
This live roundtable, chaired by Prof Marco Valgimigli (Cardiocentro Ticino Institute, Lugano, CH), will demonstrate how to prioritise bleeding and ischaemic risks in coronary arterial disease (CAD) management. Join key opinion leadersProf Diana Gorog (University of Hertfordshire, UK), Prof Felicita Andreotti (Gemelli University Hospital, Rome, IT) and Prof Eliano Navarese (University of Sassari,… View more

Anticoagulation
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 1 year ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention
Prof Federico Pappalardo is Director of CardioThoracic and Vascular Anesthesia and Intensive Care at AO SS Antonio e Biagio e Cesare Arrigo in Alessandria and at AOU Maggiore della Carità in Novara, IT. Prof Pappalardo has been Associate Professor at Vita-Salute San Raffaele University, Milan, (2017-2020), where he worked as Director of the Cardiothoracic Intensive Care Unit (2009-2018) and the… View more
Research Area(s) / Expertise:
AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 1 year ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more

Heart Failure

Intervention
ACC 25: The SMART-CHOICE 3 Trial
Author(s): Joo-Yong Hahn Added: 2 months ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel… View more

Anticoagulation

Intervention